Incidence of Glaucoma in Type 2 Diabetes Patients Treated With GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis.
Asif M, Asif A, Rahman UA, Farooqi HA, Fatima O, Ali W, Jafar U, Jaber MH.
Endocrinol Diabetes Metab. 2025 Jul;8(4):e70059. doi: 10.1002/edm2.70059.
Glaucoma: Diagnosis and Management.
Michels TC, Ivan O.
Am Fam Physician. 2023 Mar;107(3):253-262.
GLP-1 Receptor Agonists and Sight-Threatening Ophthalmic Complications in Patients With Type 2 Diabetes.
Ramsey DJ, Makwana B, Dani SS, Patel M, Panchal K, Shah J, Khadke S, Kumar A, Patel T, Kosiborod MN, Fonarow GC, Ramsey KM, Nohria A, Butler J, Ganatra S.
JAMA Netw Open. 2025 Aug 1;8(8):e2526321. doi: 10.1001/jamanetworkopen.2025.26321.
Time to Progression to Proliferative Diabetic Retinopathy in Patients With Type 2 Diabetes.
Kim IM, Radgoudarzi N, Chen EM, Liu J, Moussa K, Shantha JG, Tsui E, Gore C, Baxter SL, Porco TC, Arnold BF, Sun CQ.
JAMA Netw Open. 2025 Jul 1;8(7):e2521150. doi: 10.1001/jamanetworkopen.2025.21150.
Type 2 Diabetes, Fasting Glucose, Hemoglobin A1c Levels and Risk of Primary Open-Angle Glaucoma: A Mendelian Randomization Study.
Hu Z, Zhou F, Kaminga AC, Xu H.
Invest Ophthalmol Vis Sci. 2022 May 2;63(5):37. doi: 10.1167/iovs.63.5.37.
Aloe-emodin: A review of its pharmacology, toxicity, and pharmacokinetics.
Dong X, Zeng Y, Liu Y, You L, Yin X, Fu J, Ni J.
Phytother Res. 2020 Feb;34(2):270-281. doi: 10.1002/ptr.6532. Epub 2019 Nov 3.
Comparative Effects of Glucagon-like Peptide 1 Receptor Agonists and Metformin on Glaucoma Risk in Patients with Type 2 Diabetes.
Muayad J, Loya A, Hussain ZS, Chauhan MZ, Alsoudi AF, De Francesco T, Ahmed IIK.
Ophthalmology. 2025 Mar;132(3):271-279. doi: 10.1016/j.ophtha.2024.08.023. Epub 2024 Aug 23.
Dissecting causal associations of type 2 diabetes with 111 types of ocular conditions: a Mendelian randomization study.
Chen R, Xu S, Ding Y, Li L, Huang C, Bao M, Li S, Wang Q.
Front Endocrinol (Lausanne). 2023 Nov 22;14:1307468. doi: 10.3389/fendo.2023.1307468. eCollection 2023.
Systemic and ocular outcomes in patients with young-onset type 2 diabetes.
Au A, Bajar BT, Wong BM, Daskivich LP, Hosseini H, Prasad PS.
J Diabetes Complications. 2024 Feb;38(2):108670. doi: 10.1016/j.jdiacomp.2023.108670. Epub 2023 Dec 22.
Assessment of iris volume in glaucoma patients with type 2 diabetes mellitus by AS-OCT.
Su Y, Ge QS, Li ZY, Bu QW, Hu D, Zhou LF, Pan XJ.
Int J Ophthalmol. 2023 May 18;16(5):743-747. doi: 10.18240/ijo.2023.05.11. eCollection 2023.
